8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2020 / Uncontrolled pre-post trial with young active reference group
Sixteen middle-aged, untrained participants completed 10 weeks of full-body resistance training twice weekly, with biopsies taken pre- and post-training, and baseline comparisons made to 15 trained college-aged men. In the middle-aged participants, resistance training increased muscle NAD+ (+127%, p<0.001), NADH (+99%, p=0.002), global SIRT activity (+13%, p=0.036), NAMPT protein (+15%, p=0.014), and citrate synthase activity (+183%, p<0.001). Pre-training NAD+ and NADH were lower in middle-aged participants than young participants (p<0.05), but were similar post-training (p>0.10). The increase in citrate synthase activity was significantly associated with increases in muscle NAD+ (r2=0.592, p=0.001).
Lamb DA, Moore JH, Mesquita PHC, et al. Aging (Albany NY), 2020. PMID 32369778
2020 / Intervention trial with matched controls
Adult-onset mitochondrial myopathy patients and matched controls received increasing doses of the vitamin B3 form niacin (up to 750-1,000 mg/day) for 10 or 4 months, respectively. Blood NAD+ increased in all subjects up to 8-fold, and muscle NAD+ in patients reached control levels. Muscle strength and mitochondrial biogenesis increased in all subjects, patients' muscle metabolomes shifted toward controls, and liver fat decreased by as much as 50%, though some patients showed an anemia tendency.
Pirinen E, Auranen M, Khan NA, et al. Cell Metab, 2020. PMID 32386566
2020 / Double-blind randomized crossover trial
A double-blind, randomized crossover trial in 51 women evaluated the cognitive effects of a high-saturated-fat meal compared to a high-oleic-sunflower-oil meal 5 hours postmeal, alongside baseline endotoxemia markers. Women had more difficulty distinguishing target stimuli from distractors after the high-saturated-fat meal than after the oleic-sunflower-oil meal (B = 4.44, SE = 1.88, P = 0.02). Higher baseline LBP and LBP:sCD14 were associated with less consistent, slower, and more erratic response times. Significant interactions showed that high baseline LBP and LBP:sCD14 erased between-meal differences, uniformly impairing attention.
Madison AA, Belury MA, Andridge R, et al. Am J Clin Nutr, 2020. PMID 32393980
2020 / Single-blind randomized controlled trial
A single-blind randomized trial evaluated 60 elderly subjects assigned to receive 2 g lavender teabags twice daily as a decoction for 2 weeks or to an untreated control group. After the intervention, depression scores were significantly lower in the intervention group compared to the control group (16.33 ± 1.49 vs. 18.33 ± 1.84, P < 0.001). Mean differences between intervention and control groups were -2.00 (95% CI: -2.86, -1.13) for depression, -6.40 (95% CI: -9.43, -3.36) for state anxiety, and -4.13 (95% CI: -7.66, -0.60) for trait anxiety.
Bazrafshan MR, Jokar M, Shokrpour N, et al. Complement Ther Med, 2020. PMID 32444033
2020 / Two-period randomized crossover trial
In a randomized crossover trial, 55 adults with elevated BMI and cardiometabolic risk consumed 3/4 cup/day of mixed dried fruits (plums, figs, dates, raisins) or an isocaloric, carbohydrate-matched control snack for 4 weeks. Lipid and lipoprotein concentrations did not differ between conditions, though dried fruit increased LDL-cholesterol from baseline (0.10 mmol/l, 95% CI 0.01, 0.20). Compared with control, dried fruit increased mean fasting glucose (0.08 mmol/l, 95% CI 0.005, 0.16; P = 0.038), while vascular outcomes, fasting insulin, and C-reactive protein did not differ. Mean weight changes did not differ between groups (P = 0.55), but tended to increase in both.
Sullivan VK, Petersen KS, Kris-Etherton PM Br J Nutr, 2020. PMID 32513313
2020 / Randomized, double-blind, placebo-controlled crossover trial
In the RESHAW trial, postmenopausal women were randomized to receive resveratrol (75 mg twice daily) or placebo in a 24-month crossover design. After 12 months of resveratrol compared to placebo, bone mineral density increased in the lumbar spine (+0.016 ± 0.003 g/cm2) and neck of femur (+0.005 ± 0.002 g/cm2), accompanied by a 7.24% reduction in C-terminal telopeptide type-1 collagen levels. The femoral neck bone mineral density increase improved T-scores (+0.070 ± 0.018) and lowered 10-year fracture risk, with larger effects observed in women with poorer bone biomarker status or those taking vitamin D plus calcium.
Wong RH, Thaung Zaw JJ, Xian CJ, et al. J Bone Miner Res, 2020. PMID 32564438
2020 / Pilot double-blind randomized placebo-controlled trial
Patients with mild Alzheimer's disease were randomized to receive three 350 mg erinacine A-enriched Hericium erinaceus mycelia (EAHE) capsules per day (5 mg/g erinacine A) or placebo for 49 weeks following a 3-week screening period. After 49 weeks, the EAHE group showed significant improvement in MMSE score, a significant difference in IADL score compared to placebo, and a significant decrease in CASI score was noted only in the placebo group. The EAHE group also achieved significantly better contrast sensitivity and showed differences in biomarkers and neuroimaging ADC values compared to placebo. Four subjects dropped out due to abdominal discomfort, nausea, and skin rash, with no other adverse events reported.
Li IC, Chang HH, Lin CH, et al. Front Aging Neurosci, 2020. PMID 32581767
2020 / Randomized controlled trial (secondary analysis)
In a secondary analysis of a factorial randomized trial involving 3,365 adults followed for 22.3 years, smoking was associated with increased risk of gastric cancer incidence (OR, 1.72; 95% CI, 1.003-2.93) and mortality (HR, 2.01; 95% CI, 1.01-3.98). Garlic supplementation was associated with reduced gastric cancer mortality exclusively among individuals who never drank alcohol (HR, 0.33; 95% CI, 0.15-0.75; interaction P = .03). No significant interactions occurred between vitamin supplementation and lifestyle behaviors.
Guo Y, Li ZX, Zhang JY, et al. JAMA Netw Open, 2020. PMID 32589229
2020 / Randomized, double-blind pilot trial
An 8-week double-blind randomized clinical trial compared Melissa officinalis (2 g/day), Lavandula angustifolia (2 g/day), and fluoxetine (20 mg/day) in 45 adult outpatients with mild to moderate major depression. Outcomes were measured at weeks 0, 2, 4, and 8 using the 17-item HAM-D. The study found that M. officinalis and L. angustifolia had an effect similar to fluoxetine (F = 0.131, df = 2,42, p = 0.877). A notable limitation stated by the authors was the absence of a placebo group.
Araj-Khodaei M, Noorbala AA, Yarani R, et al. BMC Complement Med Ther, 2020. PMID 32620104
2020 / Randomized double-blind placebo-controlled trial
Fifty patients with migraine were randomized to receive either cinnamon powder (three capsules/day, each containing 600 mg) or placebo (three capsules/day of corn starch) for 2 months. Compared with the control group, serum concentrations of IL-6 and NO were significantly reduced in the cinnamon group (p < .05), while CGRP levels remained unchanged in both groups. In addition, the frequency, severity, and duration of migraine attacks significantly decreased in the cinnamon group compared to controls.
Zareie A, Sahebkar A, Khorvash F, et al. Phytother Res, 2020. PMID 32638445
2020 / Crossover, double-masked, randomized clinical trial
In a double-masked crossover trial, 57 glaucoma patients received oral placebo or nicotinamide (1.5 g/day for 6 weeks, then 3.0 g/day for 6 weeks) followed by crossover without washout. Saturated PhNR amplitude (Vmax) improved by 14.8% (95% CI: 2.8%, 26.9%; P = .02) on nicotinamide versus 5.2% (95% CI: -4.2%, 14.6%; P = .27) on placebo. The Vmax ratio improved by 12.6% (95% CI: 5.0%, 20.2%; P = .002) following nicotinamide compared to 3.6% (95% CI: -3.4%, 10.5%; P = .30) on placebo. Additionally, 27% of participants improved visual field mean deviation by ≥1 dB on nicotinamide with fewer deteriorating (4%) compared to placebo (P = .02).
Hui F, Tang J, Williams PA, et al. Clin Exp Ophthalmol, 2020. PMID 32721104
2020 / Randomized controlled trial (2 x 2 factorial)
In the VITAL-DEP randomized clinical trial, 18,353 participants aged 50 years or older were assigned to vitamin D3 (2000 IU/d) or placebo for a median duration of 5.3 years. Risk of depression or clinically relevant depressive symptoms did not significantly differ between the vitamin D3 group (12.9/1000 person-years) and placebo (13.3/1000 person-years; HR 0.97, 95% CI 0.87 to 1.09; P = .62). There were also no significant differences in depression incidence, recurrence, or change in PHQ-8 mood scores over time (mean difference 0.01 points, 95% CI -0.04 to 0.05 points).
Okereke OI, Reynolds CF, Mischoulon D, et al. JAMA, 2020. PMID 32749491
2020 / Consumer sensory evaluation study
Researchers evaluated whether using monosodium glutamate (MSG) to replace salt in four "better-for-you" dishes could match consumer acceptance while lowering sodium. A total of 163 consumers tasted standard-salt, reduced-salt, and reduced-salt plus MSG versions of roasted vegetables, a quinoa bowl, savory yogurt dip, and pork cauliflower fried rice. For all dishes, the MSG versions were liked the same as (or significantly more for the dip, P < 0.05) the standard recipe, and liked better than the reduced-salt recipe for the quinoa bowl and fried rice. MSG recipes of the quinoa bowl and dip were significantly preferred over standard recipes, leading authors to conclude MSG can mitigate sodium reduction without compromising acceptance.
Halim J, Bouzari A, Felder D, et al. J Food Sci, 2020. PMID 32776553
2020 / Randomized crossover trial
In the SWAP-MEAT crossover trial, 36 healthy adults consumed ≥2 servings/day of plant-based alternative meat versus animal meat for 8 weeks each with no washout period. Overall mean ± SEM TMAO concentrations were lower during the plant phase (2.7 ± 0.3 vs. 4.7 ± 0.9 µM, P = 0.012), though a significant order effect occurred; TMAO was significantly lower only in participants receiving plant meat second. LDL-cholesterol concentrations (109.9 ± 4.5 vs. 120.7 ± 4.5 mg/dL, P = 0.002) and body weight (78.7 ± 3.0 vs. 79.6 ± 3.0 kg, P < 0.001) were also significantly lower during the plant-based phase.
Crimarco A, Springfield S, Petlura C, et al. Am J Clin Nutr, 2020. PMID 32780794
2020 / Parallel-group, double-blind, randomized controlled trial
A parallel-group, double-blind trial randomized 159 patients with CKD stage 3b or 4 to receive 400 μg oral vitamin K2 (n=80) or matching placebo (n=79) once daily for 1 year. The study found no differences between groups in carotid-femoral pulse wave velocity at 12 months, augmentation index at 12 months, blood pressure, B-type natriuretic peptide, or physical function. Furthermore, an updated meta-analysis of trials conducted by the authors showed no effect of vitamin K supplementation on vascular stiffness or vascular calcification measures.
Witham MD, Lees JS, White M, et al. J Am Soc Nephrol, 2020. PMID 32817311
2020 / Randomized controlled trial
Ninety-nine mildly hypertensive participants aged 40-65 years completed a 4-week low-polyphenol diet (LPD) washout and were then randomized to either an LPD or a high-polyphenol diet (HPD) for 8 weeks. Participants in the HPD group reported a decrease in depressive symptoms on the Beck Depression Inventory-II, alongside improved physical and mental health component scores on the 36-Item Short Form Survey. No differences were observed for anxiety, stress, self-esteem, or body image perception.
Kontogianni MD, Vijayakumar A, Rooney C, et al. Nutrients, 2020. PMID 32823886
2020 / Randomized crossover trial
Twenty-two recreationally trained participants consumed vinegar (29 mL), sucrose (39 g), vinegar plus sucrose, or water alone in randomized order across four visits to evaluate effects on high-intensity cycling. Participants performed two cycle tests and a fatiguing test, ingested the supplement, rested for 90 minutes, and completed a third cycle test. There was no significant supplement by time interaction or main treatment effect (p > 0.05) on total time to exhaustion or heart rate.
Farney TM, Kowalsky RJ, Salazar DA, et al. Medicina (Kaunas), 2020. PMID 32867047
2020 / Randomized, double-blind, placebo-controlled crossover trial
In a 24-month randomized, double-blind, placebo-controlled crossover trial, 125 healthy postmenopausal women received resveratrol (75 mg twice daily) or placebo to assess effects on well-being and cerebrovascular function. Resveratrol supplementation significantly reduced composite pain score (P < 0.001), especially in overweight participants, and this reduction was associated with improved cerebrovascular responsiveness to hypercapnia (R = -0.329, P = 0.014). Somatic menopausal symptoms (P = 0.024) and general well-being (P = 0.010) were also improved.
Thaung Zaw JJ, Howe PRC, Wong RHX Menopause, 2020. PMID 32881835
2020 / Multicenter, randomized, double-blind, placebo-controlled trial
One hundred menopausal Korean women were randomly assigned to receive either 400 mg/day of porcine placental extract (PPE) or a placebo for 12 weeks. While the Kupperman Index (KMI) decreased in both groups, the overall difference between groups was not statistically significant. However, KMI decreased significantly more with PPE than placebo in women with BMI 23 kg/m2 or higher (-18.52 ± 9.09 vs -11.40 ± 10.68, P < 0.05) and in early menopausal women (-17.29 ± 9.07 vs -11.29 ± 10.68, P < 0.05). Estradiol levels also increased significantly in the PPE group at 12 weeks (11.13 ± 35.13 pg/m, P < 0.05).
Lee JY, Lee C, Yoon SH, et al. Taiwan J Obstet Gynecol, 2020. PMID 32917317
2020 / Randomized, placebo-controlled study
Participants were randomized to wear a novel nasal device for 5-12 hours daily or receive daily saline nasal drops, alongside a 500 kcal/day reduced diet for 12 weeks. Sense of smell decreased from 6.4 ± 0.9 to 4.4 ± 1.5 in the device group (p < 0.001) with no change in controls. Overall weight loss was 6.6 ± 3.7% in the device group versus 5.7 ± 3.5% in controls (between-group p > 0.05), but was significantly greater with the device among participants aged ≤50 years (7.7 ± 4.2% vs. 4.1 ± 2.9%, p = 0.02). The device group also showed significant reductions in insulin, HOMA-IR, and preferences for sugar, sweet beverages, and artificial sweeteners.
Dicker D, Beck A, Markel A, et al. Obes Facts, 2020. PMID 32950989
2020 / Three-phase sequential intervention study
Thirty adolescents with type 1 diabetes completed three 1-week phases: Phase I with a standard diet, followed by Phase II adding oat flakes with 3 g/day beta-glucan, and Phase III adding oat flakes with 6 g/day beta-glucan. Maximal, mean, daytime, and night blood glucose levels were lowest at Phase III, while minimal blood glucose was highest at Phase III (p < 0.05). Premeal, postmeal, and peak blood glucose values were lowest at Phase III for breakfast, lunch, and overall, with delayed peak times (p < 0.05). Phase III also significantly reduced glycemic variability metrics including SD, CV, LBGI, and CONGA compared to Phase I or II (p < 0.05), while durations in hypoglycemia, euglycemia, and hyperglycemia did not differ significantly between phases.
Bozbulut R, Şanlıer N, Döğer E, et al. Diabetes Res Clin Pract, 2020. PMID 32971156
2020 / Randomised controlled trial
Older adults (n=1567) were randomized to twice-weekly HIIT (n=400), MICT (n=387), or following national physical activity guidelines (control, n=780) for five years. All-cause mortality did not differ between the control group and the combined MICT and HIIT group. Compared with controls (4.7% observed mortality), absolute risk reduction was 1.7 percentage points after HIIT (HR 0.63, 95% CI 0.33 to 1.20) and absolute increased risk was 1.2 percentage points after MICT (HR 1.24, 95% CI 0.73 to 2.10). Comparing HIIT to MICT, absolute risk reduction was 2.9 percentage points (HR 0.51, 95% CI 0.25 to 1.02). Controls performed more of their physical activity as HIIT than the MICT group did, achieving an exercise dose between MICT and HIIT.
Stensvold D, Viken H, Steinshamn SL, et al. BMJ, 2020. PMID 33028588
2020 / Randomized controlled trial (DIRECT-PLUS trial component) and lab assays
Researchers analyzed the vitamin B12 content of Wolffia globosa (Mankai) using lab assays and tested the effects of consuming 100 g/day of Mankai shake in an 18-month weight-loss trial (DIRECT-PLUS, n=294). Several bioactive cobalamin congeners were identified in Mankai extracts, with no pseudo B12 detected. Over 18 months, serum B12 levels increased by 5.2% in the control group, 9.9% in the Mediterranean diet group, and 15.4% in the green Mediterranean/low-meat diet group consuming Mankai (p = 0.025 between extreme groups).
Sela I, Yaskolka Meir A, Brandis A, et al. Nutrients, 2020. PMID 33049929
2020 / Randomized two-group parallel-arm study
A randomized parallel-arm study evaluated the effects of 16 weeks of either 85 g or 250 g of Ataulfo mango intake on facial wrinkles and erythema in healthy postmenopausal women with Fitzpatrick skin type II or III. In the 85 g group, deep wrinkle severity decreased significantly after 8 weeks (p = 0.007) and 16 weeks (p = 0.03) compared to baseline, while cheek erythema increased (p = 0.04). In contrast, the 250 g group showed significant increases after 16 weeks in average wrinkle severity (p = 0.049), average wrinkle length (p = 0.007), fine wrinkle severity (p = 0.02), and emerging wrinkle severity (p = 0.02).
Fam VW, Holt RR, Keen CL, et al. Nutrients, 2020. PMID 33158079